Exosomal miR-21 beats serum carcinoembryonic antigen in detecting patients having gastric cancer (GC) as well as patients having precancerous lesions (PC), according to the receiver operating characteristic curve created throughout clinical sample analysis (area under the curve: 0.89 versus 0.74, n = 40). This evidence concerns the gene CEACAM5 and gastric cancer.